LDLR and nephrotic syndrome: Findings report that patients with nephrotic syndrome have reduced LDL-receptor activity but increased acyl-CoA cholesterol acyltransferase (ACAT) and HMG-CoA reductase activity, which results in higher LDL-cholesterol levels [61].